Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury

John H. Peters, Richard J. Maunder, Anthony D. Woolf, Charles G. Cochrane, Mark H. Ginsberg

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Using an enzyme-linked immunosorbent assay, we measured the concentration of fibronectin containing an extra type III domain (ED1) in the circulation of humans. Plasma levels of ED1+ fibronectin averaged 2.8 ± 1.0 μg/ml in healthy individuals and did not differ substantially according to age or sex. In comparison with those from normal subjects, plasma samples obtained from patients with collagen vascular disorders contained increased average levels of ED1 + fibronectin. Among this group, levels of ED1 + fibronectin were significantly greater in samples taken from individuals with clinical evidence of vasculltis. Although levels of total (ED 1+ plus ED1-) fibronectin were also elevated in plasma samples from patients with vasculitis, only the concentration of the ED1 + variant correlated with severity of disease in two patients examined serially. Elevations in plasma content of ED1 + fibronectin, but not total fibronectin, were also noted in patients with acute vascular tissue injury associated with major trauma or sepsis syndrome. Western blot examination revealed the presence of intact dimeric ED1 + fibronectin in the circulation of all patients studied, although nfragments bearing the ED1 were also detected. Human plasma normally contains small quantities of solubie ED1 + ("cellular") fibronectin, and these levels are increased in disorders involving vascular injury.

Original languageEnglish (US)
Pages (from-to)586-597
Number of pages12
JournalThe Journal of Laboratory and Clinical Medicine
Volume113
Issue number5
StatePublished - 1989
Externally publishedYes

Fingerprint

Vascular System Injuries
Fibronectins
Plasmas
Bearings (structural)
Plasma (human)
Systemic Inflammatory Response Syndrome
Immunosorbents
Vasculitis
Blood Vessels
Assays
Collagen
Western Blotting
Enzyme-Linked Immunosorbent Assay
Tissue
Wounds and Injuries
Enzymes

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Peters, J. H., Maunder, R. J., Woolf, A. D., Cochrane, C. G., & Ginsberg, M. H. (1989). Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. The Journal of Laboratory and Clinical Medicine, 113(5), 586-597.

Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. / Peters, John H.; Maunder, Richard J.; Woolf, Anthony D.; Cochrane, Charles G.; Ginsberg, Mark H.

In: The Journal of Laboratory and Clinical Medicine, Vol. 113, No. 5, 1989, p. 586-597.

Research output: Contribution to journalArticle

Peters, JH, Maunder, RJ, Woolf, AD, Cochrane, CG & Ginsberg, MH 1989, 'Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury', The Journal of Laboratory and Clinical Medicine, vol. 113, no. 5, pp. 586-597.
Peters, John H. ; Maunder, Richard J. ; Woolf, Anthony D. ; Cochrane, Charles G. ; Ginsberg, Mark H. / Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. In: The Journal of Laboratory and Clinical Medicine. 1989 ; Vol. 113, No. 5. pp. 586-597.
@article{ed51b0c2ba754c07aa3e608675465c65,
title = "Elevated plasma levels of ED1+ ({"}cellular{"}) fibronectin in patients with vascular injury",
abstract = "Using an enzyme-linked immunosorbent assay, we measured the concentration of fibronectin containing an extra type III domain (ED1) in the circulation of humans. Plasma levels of ED1+ fibronectin averaged 2.8 ± 1.0 μg/ml in healthy individuals and did not differ substantially according to age or sex. In comparison with those from normal subjects, plasma samples obtained from patients with collagen vascular disorders contained increased average levels of ED1 + fibronectin. Among this group, levels of ED1 + fibronectin were significantly greater in samples taken from individuals with clinical evidence of vasculltis. Although levels of total (ED 1+ plus ED1-) fibronectin were also elevated in plasma samples from patients with vasculitis, only the concentration of the ED1 + variant correlated with severity of disease in two patients examined serially. Elevations in plasma content of ED1 + fibronectin, but not total fibronectin, were also noted in patients with acute vascular tissue injury associated with major trauma or sepsis syndrome. Western blot examination revealed the presence of intact dimeric ED1 + fibronectin in the circulation of all patients studied, although nfragments bearing the ED1 were also detected. Human plasma normally contains small quantities of solubie ED1 + ({"}cellular{"}) fibronectin, and these levels are increased in disorders involving vascular injury.",
author = "Peters, {John H.} and Maunder, {Richard J.} and Woolf, {Anthony D.} and Cochrane, {Charles G.} and Ginsberg, {Mark H.}",
year = "1989",
language = "English (US)",
volume = "113",
pages = "586--597",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury

AU - Peters, John H.

AU - Maunder, Richard J.

AU - Woolf, Anthony D.

AU - Cochrane, Charles G.

AU - Ginsberg, Mark H.

PY - 1989

Y1 - 1989

N2 - Using an enzyme-linked immunosorbent assay, we measured the concentration of fibronectin containing an extra type III domain (ED1) in the circulation of humans. Plasma levels of ED1+ fibronectin averaged 2.8 ± 1.0 μg/ml in healthy individuals and did not differ substantially according to age or sex. In comparison with those from normal subjects, plasma samples obtained from patients with collagen vascular disorders contained increased average levels of ED1 + fibronectin. Among this group, levels of ED1 + fibronectin were significantly greater in samples taken from individuals with clinical evidence of vasculltis. Although levels of total (ED 1+ plus ED1-) fibronectin were also elevated in plasma samples from patients with vasculitis, only the concentration of the ED1 + variant correlated with severity of disease in two patients examined serially. Elevations in plasma content of ED1 + fibronectin, but not total fibronectin, were also noted in patients with acute vascular tissue injury associated with major trauma or sepsis syndrome. Western blot examination revealed the presence of intact dimeric ED1 + fibronectin in the circulation of all patients studied, although nfragments bearing the ED1 were also detected. Human plasma normally contains small quantities of solubie ED1 + ("cellular") fibronectin, and these levels are increased in disorders involving vascular injury.

AB - Using an enzyme-linked immunosorbent assay, we measured the concentration of fibronectin containing an extra type III domain (ED1) in the circulation of humans. Plasma levels of ED1+ fibronectin averaged 2.8 ± 1.0 μg/ml in healthy individuals and did not differ substantially according to age or sex. In comparison with those from normal subjects, plasma samples obtained from patients with collagen vascular disorders contained increased average levels of ED1 + fibronectin. Among this group, levels of ED1 + fibronectin were significantly greater in samples taken from individuals with clinical evidence of vasculltis. Although levels of total (ED 1+ plus ED1-) fibronectin were also elevated in plasma samples from patients with vasculitis, only the concentration of the ED1 + variant correlated with severity of disease in two patients examined serially. Elevations in plasma content of ED1 + fibronectin, but not total fibronectin, were also noted in patients with acute vascular tissue injury associated with major trauma or sepsis syndrome. Western blot examination revealed the presence of intact dimeric ED1 + fibronectin in the circulation of all patients studied, although nfragments bearing the ED1 were also detected. Human plasma normally contains small quantities of solubie ED1 + ("cellular") fibronectin, and these levels are increased in disorders involving vascular injury.

UR - http://www.scopus.com/inward/record.url?scp=0024544158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024544158&partnerID=8YFLogxK

M3 - Article

VL - 113

SP - 586

EP - 597

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 5

ER -